Zymeworks BC Inc.
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Zymeworks Inc. (to 2022)
0
Ending by 2030
Mar 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 23, 2027The maintenance fee for Multivalent Heteromultimer Scaffold Design and Constructs (US 10,358,479) comes due Jan 23, 2027. Unpaid by Jul 23, 2027, it lapses early.
- 1 fee due Mar 17, 2027The maintenance fee for Cytotoxic and anti-mitotic compounds, and methods of using the same (US 10,414,822) comes due Mar 17, 2027. Unpaid by Sep 17, 2027, it lapses early.
- 2 fees due Apr 22 to 29, 2027 · next Apr 22
- 1 fee due Jun 17, 2027The maintenance fee for Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells (US 10,508,154) comes due Jun 17, 2027. Unpaid by Dec 17, 2027, it lapses early.
- 1 fee due Sep 29, 2027The maintenance fee for Antibodies with enhanced or suppressed effector function (US 9,296,815) comes due Sep 29, 2027. Unpaid by Mar 29, 2028, it lapses early.
- 2 fees due Oct 23, 2027
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,499,605 | Multivalent Heteromultimer Scaffold Design and Constructs In force · High confidence | In force | High confidence | |
| US 10,155,803 | Multivalent Heteromultimer Scaffold Design and Constructs In force · High confidence | In force | High confidence | |
| US 10,711,051 | Multivalent Heteromultimer Scaffold Design and Constructs In force · High confidence | In force | High confidence | |
| US 10,875,931 | Stable heterodimeric antibody design with mutations in the Fc domain In force · From the USPTO record | In force | From the USPTO record | |
| US 9,296,815 | Antibodies with enhanced or suppressed effector function In force · From the USPTO record | In force | From the USPTO record | |
| US 10,457,742 | Stable heterodimeric antibody design with mutations in the Fc domain In force · From the USPTO record | In force | From the USPTO record | |
| US 10,508,154 | Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells In force · From the USPTO record | In force | From the USPTO record | |
| US 9,388,231 | Multivalent Heteromultimer Scaffold Design and Constructs In force · High confidence | In force | High confidence | |
| US 10,358,479 | Multivalent Heteromultimer Scaffold Design and Constructs In force · High confidence | In force | High confidence | |
| US 9,771,573 | Methods of Quantitating Heavy and Light Chain Polypeptide Pairs In force · High confidence | In force | High confidence |
Also on record, not counted in the 48: 3 patents in force now held by others · 6 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
16 pending · 1 abandoned · 9 no status recorded